STAT1 and hepatocellular carcinoma: HDAC2 recruits STAT1 to the ACKR3 promoter, driving its transcription and supporting TAM infiltration, while HDAC2 inhibition prevents STAT1 nuclear translocation, reinforcing its role in HCC progression [143].